JP2024540894A5 - - Google Patents
Info
- Publication number
- JP2024540894A5 JP2024540894A5 JP2024523176A JP2024523176A JP2024540894A5 JP 2024540894 A5 JP2024540894 A5 JP 2024540894A5 JP 2024523176 A JP2024523176 A JP 2024523176A JP 2024523176 A JP2024523176 A JP 2024523176A JP 2024540894 A5 JP2024540894 A5 JP 2024540894A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- polynucleotide according
- polynucleotide
- peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256960P | 2021-10-18 | 2021-10-18 | |
| US202163256875P | 2021-10-18 | 2021-10-18 | |
| US63/256,960 | 2021-10-18 | ||
| US63/256,875 | 2021-10-18 | ||
| PCT/US2022/078305 WO2023069950A1 (en) | 2021-10-18 | 2022-10-18 | Recombinant rotavirus expressing exogenous protein and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540894A JP2024540894A (ja) | 2024-11-06 |
| JP2024540894A5 true JP2024540894A5 (enExample) | 2025-10-23 |
Family
ID=86058612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523176A Pending JP2024540894A (ja) | 2021-10-18 | 2022-10-18 | 外因性タンパク質を発現する組換えロタウイルス及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250263443A1 (enExample) |
| EP (1) | EP4419134A4 (enExample) |
| JP (1) | JP2024540894A (enExample) |
| KR (1) | KR20240099298A (enExample) |
| AU (1) | AU2022368902A1 (enExample) |
| CA (1) | CA3235965A1 (enExample) |
| WO (1) | WO2023069950A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12173032B2 (en) | 2018-07-13 | 2024-12-24 | The Trustees Of Indiana University | Recombinant rotavirus expression system and recombinant rotaviruses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643756A (en) * | 1992-08-28 | 1997-07-01 | The Public Health Research Institute Of The City Of New York, Inc. | Fusion glycoproteins |
| WO2008009727A1 (en) * | 2006-07-21 | 2008-01-24 | Centre National De La Recherche Scientifique (Cnrs) | Positive cytomodulines to improve bioreactor productivity. |
| WO2010042490A1 (en) * | 2008-10-06 | 2010-04-15 | Boston Medical Center Corporation | A single lentiviral vector system for induced pluripotent (ips) stem cells derivation |
| US12173032B2 (en) * | 2018-07-13 | 2024-12-24 | The Trustees Of Indiana University | Recombinant rotavirus expression system and recombinant rotaviruses |
-
2022
- 2022-10-18 CA CA3235965A patent/CA3235965A1/en active Pending
- 2022-10-18 KR KR1020247016366A patent/KR20240099298A/ko active Pending
- 2022-10-18 EP EP22884645.7A patent/EP4419134A4/en active Pending
- 2022-10-18 JP JP2024523176A patent/JP2024540894A/ja active Pending
- 2022-10-18 AU AU2022368902A patent/AU2022368902A1/en active Pending
- 2022-10-18 WO PCT/US2022/078305 patent/WO2023069950A1/en not_active Ceased
- 2022-10-18 US US18/702,470 patent/US20250263443A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11826416B2 (en) | Induce and enhance immune responses using recombinant replicon systems | |
| AU2019359204B2 (en) | Alphavirus-based replicons for administration of biotherapeutics | |
| ES2326703T3 (es) | Vacuna para el virus del sindrome reproductivo y respiratorio porcino. | |
| ES2229269T3 (es) | Sistema de replicones de arn de alfavirus. | |
| Roy et al. | African horse sickness virus structure | |
| CN116472279A (zh) | 麻疹载体covid-19免疫原性组合物和疫苗 | |
| BR112019019813A2 (pt) | moléculas quiméricas e usos das mesmas | |
| JP2015522581A5 (enExample) | ||
| JP2016521539A5 (enExample) | ||
| JP2023521662A5 (enExample) | ||
| RU2005113692A (ru) | Вакцина против hcv | |
| JP2025169275A5 (enExample) | ||
| ES2585735T3 (es) | Nuevas proteínas de fusión y su aplicación para la preparación de vacunas contra la hepatitis C | |
| Gorziglia et al. | VP7 serotype-specific glycoprotein of OSU porcine rotavirus: coding assignment and gene sequence | |
| ES3056141T3 (en) | Simian adenoviral vectors with two expression cassettes | |
| JP2024503108A5 (enExample) | ||
| Rao et al. | Comparative nucleotide and amino acid sequence analysis of the sequence-specific RNA-binding rotavirus nonstructural protein NSP3 | |
| Morozov et al. | In vitro membrane binding of the translation products of the carlavirus 7-kDa protein genes | |
| WO2019076882A1 (en) | ADENOVIRAL VECTORS COMPRISING TWO EXPRESSION CASSETTES ENCODING RSV ANTIGENIC PROTEINS OR FRAGMENTS THEREOF | |
| JP2024542126A5 (enExample) | ||
| WO2022043908A1 (en) | Modified polypeptides with improved properties | |
| JP2020522249A5 (enExample) | ||
| CN118725051A (zh) | 一种犬瘟热病毒重组抗原及其在制备犬瘟疫苗中的应用 | |
| RU2019113940A (ru) | Мозаичные вакцины от вируса ящура серотипа а | |
| KR20200053825A (ko) | 3가지 혈청형의 구제역 바이러스 항원을 동시에 발현하는 구제역 백신용 재조합 아데노바이러스 |